{
    "2019-03-10": [
        [
            {
                "time": "",
                "original_text": "为节省挂牌相关成本与开支，药明康德同意控股子公司合全药业摘牌新三板",
                "features": {
                    "keywords": [
                        "药明康德",
                        "合全药业",
                        "新三板",
                        "摘牌",
                        "成本",
                        "开支"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：同意子公司合全药业申请股票终止挂牌",
                "features": {
                    "keywords": [
                        "药明康德",
                        "合全药业",
                        "终止挂牌",
                        "股票"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：董事会同意控股子公司合全药业申请新三板终止挂牌",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事会",
                        "合全药业",
                        "新三板",
                        "终止挂牌"
                    ],
                    "sentiment_score": -0.25,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}